Twenty-eight mutations, representing mutation in five different polypeptide-coding regions of the foot-and-mouth disease genome, were examined for their effect on the virulence of the virus for suckling mice. Five types of mutation were examined: temperature-sensitive (ts), electrophoretic (e), co-variant temperature-sensitive and electrophoretic (ts/e), guanidine-resistant (gs +) and putative co-variant guanidineresistant and electrophoretic (gs+/e). All the ts mutations and three out of the 11 non-ts mutations produced some reductions in virulence. In the majority of cases this reduction in virulence was shown to co-vary with the mutation. No correlation was observed between the site of a mutation or its 'cut-off' temperature and the extent of the reduction in virulence.
INTRODUCTION
One of the long-range goals of animal virus genetics is the fuller understanding of in vivo virulence and pathogenesis, which could then be exploited in the control of virus infection, e.g. construction of attenuated live virus vaccines. However, since virulence is obviously a complex function of variables, it is likely that several, if not all, of the virus genes are involved. The most illuminating studies on this subject have been done using viruses with segmented genomes, such as reoviruses (Fields et aL, 1979) , myxoviruses (Rott, 1979) and bunyaviruses (Gentsch et al., 1980) . Using the phenomenon of high-frequency gene reassortment which occurs in these viruses, it has been possible to examine the effect on virulence of substituting entire gene segments. This has shown that, in both reovirus and influenza virus, many important biological functions are determined by a single external polypeptide of the virion, the haemagglutinin. In addition, for influenza it has also been shown that substitution of almost any gene segment alters the virulence of the recipient virus. This has given rise to the concept that a constellation of genes is responsible for virulence (Scholtissek et al., 1977) . However, in molecular terms, substitution of an entire gene is a major alteration in the virus genome and could well have secondary effects unrelated to the specific function of the 0022-1317/81/0000-4461 $02.00 ~) 1981 SGM substituted gene. Mutations should act as more delicate and versatile tools for the analysis of virulence, and it should be possible to examine the effect of different sorts of mutations at different sites on the genome and even within individual genes. Conditional lethal mutants (generally temperature-sensitive) from several groups of RNA-containing viruses (myxoviruses, paramyxoviruses, reoviruses, rhabdoviruses, togaviruses and picornaviruses) have been examined for virulence in vivo (Fraenkel-Conrat & Wagner, 1977) . The results obtained previously in our laboratory with ts mutants of foot-and-mouth disease (FMD) virus (Mackenzie, 1975; Lake, 1975 ; J. R. Lake & R. A. J. Priston, unpublished results) are typical of the sort of results obtained with such mutants, namely, that most mutants are less virulent than the parental virus, irrespective of their physiological and genetic differences. However, in all such studies there has been no clear demonstration that the mutations were responsible for the reduced virulence of the mutants and/or no information on the precise location of the mutations on the genome. In the present study we have examined a selection of mutants, principally ts, whose location is known in one of five different virus-coded polypeptides. We have also examined revertants from such mutants and found, in the majority of cases, co-variation between the mutation and the reduced virulence of the mutant for infant mice.
METHODS

Viruses
Mutants. The mutants used in this study were a selection of temperature-sensitive (ts), guanidine-resistant (gs +) and electrophoretic (e) mutants derived from the Pacheco strain of FMD virus, type O. The isolation and genetic mapping of the ts mutations and one gs + mutation [ts+gs+(J.L.) ] have been described previously Lake et al., 1975; McCahon et al., 1977) . The additional gs + mutations were isolated as second mutations of existing ts mutants, as described previously .
The e mutations cause shifts in the isoelectric points of virus-coded polypeptides and can be detected by isoelectric focusing ; A. M. Q. King, J. W. L Newman & K. Saunders, unpublished results). All e mutations were originally discovered in ts or gs + mutants. The co-variant reversion test was used to determine whether temperature sensitivity and charge change were caused by a single mutation (denoted by ts/e). The mutations (e and ts) were assumed to be independent of each other in cases where ts + revertants invariably retained the charge change . In such revertants the phenotype of the e mutation can be studied in isolation. In the present study six non-temperature-sensitive e mutations (see Tables 1 and 2) were examined in this form. All the e mutations are physically distinct on the basis of the size or nature of their charge change or their polypeptide location except for the class h mutants in VP2 (see Table 1 ) and the P56a mutations in ts 115 and ts 40 ( Table 2 ). The class h mutants are a group of ts mutants, all of which possess the same e mutation in the same 10000 mol. wt. fragment of VP2 . The two identical e mutations in P56a differ in their temperature sensitivity: in ts 115 the e mutation co-varies with the ts mutation (i.e. a ts/e mutation), whereas in ts 40 the ts mutation co-varies with an e mutation in VP1 and not with the e mutation in P56a.
The location of each of the non-electrophoretic ts mutations (12, Els, 32, 49, 16, 03, 102, 119 and 19) is based on the alignment of the genetic (McCahon et al., 1977) and biochemical (Sangar, 1979) maps of the genome derived from electrofocusing studies  A. M. Q. King, J. W. I. Newman & K. Saunders, unpublished results). In particular, seven of these mutants (12, Els, 32, 49, 16, 03 and 19) have been used as standards in genetic studies Lake et al., 1975; McCahon et aL, 1977) and, therefore, their location in relation to each other and to the other mutants used in the present study is well established. However, the error in recombination mapping is such that the ts mutation, especially in the case of those in the structural protein region, could be in the adjacent polypeptide-coding region of the genome to that indicated in Table 1 .
In the case of the five gs + mutants, three have been shown to have an e mutation in P34 which is not present in the gs parent virus (K. Saunders & A. M. Q. King, unpublished observations) . In addition, the ts mutant 16, which has a gs + mutation which co-varies with the ts mutation, has been shown in extensive recombination tests to be in the P34-coding, region of the genetic map according to the alignment of the genetic and biochemical maps of the genome referred to above. Of approx. 100 mutants (ts, gs + and cold-sensitive) examined for charge changes in their polypeptides (non-structural and structural) only four have been altered in P34, all four being gs + mutations (A. M. Q. King, K. Saunders & J. W. I. Newman, unpublished results). Therefore, it was assumed that all the gs + mutations used in this study were in P34.
Revertants. The isolation of the ts + revertants has been described previously . In the case of ts/e mutants, only revertants which showed reversion in both markers were used.
Virus assays. These were performed in BHK21 cells as described previously (McCahon et aL, 1977) , using monolayers in 90 mm Petri dishes.
'Cut-off" temperature of ts mutants. This was examined in a plaque assay in BHK21 monolayers (90 mm dishes) incubated in sealed boxes in water baths accurately controlled to temperatures of 37, 38, 38.5, 39, 39.5 and 40 °C. A minimum of 200 plaques were observed at 37 °C (the permissive temperature) and the cut-off temperature was taken as that temperature at which there was a marked change in the appearance of the plaques (from clear to faint at at least a twofold reduction in diameter) and at least a 50% reduction in plaque number.
EJficiency of plating at 41 o C ( e.o.P.41) of ts mutants.
This was a measure of the temperature sensitivity of the virus in a plaque assay and was calculated by dividing the titre at the restrictive temperature (41 °C) by the titre at the permissive temperature (36.7 °C).
Mouse virulence test. Two strains of albino mice were used in parallel in all experiments. These were the Pirbright strain and Charles River CDI strain. No differences in susceptibility to the virus were seen between these two strains. Mice (4 or 5 days old) were injected intraperitoneally (i.p.) with 0.03 ml serial fivefold virus dilutions, a total of eight mice per dilution. The mice were observed for clinical signs over 6 days. Characteristically, the first clinical signs were paralysis of the hind leg adjacent to the site of injection at approx. 60 h after inoculation. Over the next 24 h the paralysis in affected mice became generalized and death resulted within the next 24 h. However, mice were normally sacrificed at the first clear signs of paralysis. The median lethal dose (LDso) was calculated by the method of Reed & Muench (1938) . The same virus dilutions were used in the tissue culture assay at 36.7 °C to determine p.f.u./ml.
All the mutants grew and produced plaques in B HK21 cells at 36.7 o C as efficiently as ts +. However, not all the stocks were prepared in the same batch of cells or from the same number of cells and, therefore, the p.f.u./ml value varied. Since the plaque assay represented the most accurate and sensitive method available for measuring the concentration of infective virus, the virulence of the viruses was expressed as a ratio of the LDso and p.f.u, values. For convenience in presenting the data in the tables, this ratio was multiplied by 1000. This ratio was extremely variable both for ts + and for the mutants both within and between experiments. The variability is best illustrated by the values attained with ts +, which was included in all experiments. In 23 experiments involving five different stocks of ts ÷, the LDs0/p.f.u. x 103 values varied between 12 and 155 (mean = 39). Therefore, viruses with values of 12 (the lowest value seen with ts +) or greater were considered to be as virulent as ts + (see Table 1 , 2 and 3) and those with values less than 12 regarded as having reduced virulence. The majority of mutants were examined at least twice and, where appropriate, revertants or parent viruses were examined in the same test as the mutants. Invariably, such revertants or parent viruses were more virulent than the mutants (see Table 1 , 2 and 3), showing that the avirulence of the mutants was a real phenomenon and not an artefact due to the variability of the test.
Extraction of virus from suckling mice. In the investigation of the growth of the mutants in vivo (Fig. 1) extracts were prepared as follows. After removal of head, lower joints of limbs, skin and viscera, the carcases were ground with sterile sand in 0.5 ml tissue culture medium, using a pestle and mortar. A further 2.5 ml medium was added and the extract was then clarified by centrifugation. The virus content was assayed at 36.7 and 41.1 o C and the results were expressed as p.f.u./g mouse tissue.
RESULTS
Effect of mutation in structural proteins on virulence
Twenty-seven isolates, representing 15 different mutations (Table i) , were examined. The first five mutants listed (33, 37, 44, 58 and 65) have all been shown to have an identical ts/e mutation in the same fragment (tool. wt. 10 000) of VP2 and were therefore regarded as being different isolates of the same mutation. The five non-temperature-sensitive e mutations were examined as ts + revertants &the double mutants ts 12, 16, 22, 58 and 109.
All 14 ts mutants, whether ts or ts/e and irrespective of their site, were less virulent than parental ts + virus and, with only two exceptions (ts 12 and ts 109), all regained parental levels of virulence on reversion to ts +. The virulence values of 8.3 to 662 seen with revertants of ts 58 and ts 44 were regarded as equivalent to 100%, since other revertants for the same mutation gave values closer to 100% and up to 13-fold variation was found even with different stocks of ts + measured in the same experiment (see Methods). Therefore, we conclude that, except for ts 12 and ts 109, the ts mutations were solely responsible for the reduction in mouse virulence seen with these mutants. In the ease of ts 12 and ts 109, since they did regain some virulence on reversion to ts +, we conclude that the ts mutation was partly responsible for their reduced virulence and that possibly their second e mutation (in VP1, see Table 1 ) also contributed. If so, they were the only non-temperature-sensitive e mutations to have a significantly lower virulence than parental ts + virus. However, in the absence of e + revertants, it is not possible to conclude that the e mutation was responsible for the lower virulence. The two isolates of the e mutation in VP2 of ts 22 (R22 and R66) varied considerably in their mouse virulence but, since one revertant (R66) possessing the e mutation had a virulence similar to ts +, it was concluded that this was the true effect of the e mutation.
Effect of mutation in non-structural proteins on virulence
Fourteen isolates representing 13 different mutations were examined (Tables 2 and 3 ). All six ts mutants in P56a (Table 2) , whether ts or ts/e, were less virulent than the parent ts + virus. All regained parental levels of virulence on reversion to ts + on at least one occasion. The value obtained for the revertant of ts 19 was low but in the context of the experiment in which it was tested it was considered to be not significantly different from ts +. One revertant of ts 22 did not regain complete virulence to ts + (LD~0/p.f.u. x 103 = 1.9) but this could have been due to an intragenic suppression event that caused reversion of the ts and e phenotypes but not of the mouse virulence phenotype. The fact that one revertant did show co-reversion of all three markers indicated that the same mutation was responsible for all three phenotypes. The e mutation in P56a, present in ts + revertants of ts 40, gave high values but, in view of the variability referred to in Methods, these were not considered to be significantly different from parental ts + values. * All e mutations are physically distinct except for the class h mutants. The location of the ts mutations is based on recombination data and is therefore less precise than for e mutations (see Methods).
t Determined as described in Methods. :~ Ratio of titres obtained in mice and tissue culture for the same stock done on the same day. Revertants were always examined in parallel with their respective mutants. Values of 12 or more were regarded as equivalent to ts + (see Methods).
§ NA, Not applicable.
Only one of the mutations in the P34 coding region (gs + in tsgs + 107) produced a dearly significant lowering of the virulence of the virus (Table 3) . However, all of the remaining five mutations had values that were not considered to be different from parental ts + or parental gs virus, whichever was appropriate, in view of the variability in such ratios.
Growth of ts mutants in suckling mice
The determination of the LDs0/P.f.u. value for a virus was essentially a titration of the virus in suckling mice and tissue culture. Therefore, the mice were generally infected at very low doses close to the limit dilution and the appearance of clinical signs was recorded over 6 days. All of the mutants produced such signs but the proportion of mice affected varied considerably; hence the differences in the LD~0/p.f.u. rates. It was therefore important to determine whether these differences were due to differences in the ability of the mutants to D. McCAHON AND OTHERS * All e mutations are physically distinct but the two gs + mutations (107 and 115) have not been distinguished from each other (see Methods).
t Determined as described in Methods. :~ This is the ratio of the titres obtained in mice and tissue culture for the same stock done on the same day. Revertants or gs parents viruses were examined in parallel with their respective mutants. Values of 12 or more were regarded as equivalent to ts + (see Methods).
infect and grow in mice and/or to differences in the frequency of production of virulent revertants. Seven ts mutants were chosen for comparison with the parental ts + virus. These mutants were representative of mutations in each of the five polypeptide-coding regions (ts 65 in VP2, ts 49 and ts 107 in VP3, ts 103 in VP1, ts 16 in P34, ts 22 and ts 115 in P56) and had LDs0/P.f.u. x 103 values varying from 6.7 for ts 16 to 0.002 for ts 49. For each virus 40 suckling mice were inoculated (i.p.) with 104.7 p.f.u./0.03 ml. All inocula were assayed on the same day as the mice were inoculated and the range of values was 104.4 to 104.9 p.f.u./0.03 ml. The mice were examined at the times indicated in Fig. 1 for clinical signs and pairs of apparently healthy mice were sacrificed at each time point to monitor virus growth. In addition, a selection of clinically ill mice (the signs varied from slight paralysis to generalized paralysis and death) were collected (three or four mice/virus) and their virus content was assayed at the permissive and restrictive temperatures. For simplicity, the results for ts 16 and ts 22 have been omitted since they resembled ts ÷ and ts 115 respectively. Only ts 49 was very different from ts + in its growth and in the production of clinical signs. It grew to only one-thousandth of the titre seen with ts + and the other mutants and this could well explain the total lack of clinical signs. It did produce clinical signs (death) in one mouse at 81 h post-inoculation and, when this was assayed, it contained 105.6 p.f.u./g mouse tissue of apparently ts + revertant virus (e.o.p.41 ---1.0). The remaining six mutants grew to the same titre as ts + but ts 65 and (to a lesser extent) ts 107, ts 115 and ts 22 were slightly slower in their rate of growth and this was reflected in the delayed appearance of clinical signs. For all six mutants and ts + the appearance of clinical signs appeared to be related to the production of virus. In every case, clinical signs first appeared (10% morbidity) when the virus titre reached approx. 105.9 p.f.u./g mouse tissue. Clinically ill mice did not contain a larger amount of virus than apparently healthy mice and there were no significant differences between ts + and the mutants. The mean value for 24 clinically ill mice was 106"1 (range 105.4 to 107.0 ) p.f.u./g mouse tissue and, except for the single ts 49-infected mouse, the virus from mutant-infected mice was still ts. Therefore, it was concluded that, except for ts 49, the reduced virulence of the mutants was not because they were unable to grow in mice, nor were the different LDs0/p.f.u. values related to the frequency of production of ts + revertants of individual mutations. 
Correlation between cut-off temperature and mouse virulence of ts mutants
The above results show a strong correlation between temperature-sensitive mutations and reduced virulence. Sixteen out of the 17 ts mutations produced some reduction in mouse virulence compared to only three of the 11 other mutations. In view of the often-suggested correlation between cut-off temperature and virulence (Fenner, 1968) , we examined the cut-off temperature of all the ts mutants in the same experiment (see Methods). No apparent correlation was seen between the LD~0/p.f.u. value and the cut-off temperature of a ts mutant (Fig. 2) .
DISCUSSION
The main conclusion of these studies is that the virulence of this strain of FMD virus can be reduced by a single missense mutation at any one of several sites on the genome. Not all mutations led to reduced virulence but temperature-sensitive mutations (whether ts or ts/e) appeared to do so more frequently than any of the other types examined. The reason for the frequent reduced virulence of ts mutants remains a mystery. Their reduced virulence was apparently not related to the cut-off temperature for the mutation and indeed even the avirulent mutant (ts 49) had a cut-off temperature of 39 °C, which was higher than the normal body temperature of the suckling mouse (38 °C under our housing conditions; Bernstein, 1966) . The degree of reduction in virulence of a mutant appeared to be due to the mutation and was not a reflection of its reversion frequency to ts +. The growth in vivo experiment suggests that for many of the mutations the reduced virulence could well be a trivial effect of a reduced growth rate in all cells or inefficiency in infecting cells rather than a specific block in the disease process. Six out of the seven mutants with reduced virulence were able to grow to ts+-like levels and cause clinical signs in approx. 100% of mice. This apparent contradiction between the growth experiment and the LDs0/p.f.u. value was probably due to the relative size of the inoculum used in the two tests. In the LDs0 titration the mice were infected at or near to the limit dilution and many more successful cycles of replication would be required to reach the titre of 106 p.f.u./g mouse tissue that was found to be associated with clinical signs. Thus, the LDs0 titration was probably more sensitive to the small differences found in the growth experiment and this gave rise to the different LDs0/P.f.u. values. If this interpretation of the basis of their reduced virulence is correct, then such mutants would be unsuitable for use as live vaccines. One might expect that, even in the absence of reversion to virulence, the mutant virus would grow to wild-type levels in some cattle and produce clinical signs.
However, the growth experiment also clearly demonstrated that mutant ts 49 was very different from the other six mutants and from ts +. Its pattern of growth suggests that it was able to replicate successfully at an initial site (in the first 20 h after inoculation) but subsequently was unable to multiply at secondary sites. If this represents a specific block in the growth and spread of the virus through the host, then such a mutant will be very valuable in studying the pathogenesis of the virus and probably is the only avirulent mutant of all those studied.
In the previous work (Mackenzie, 1975; Lake, 1975 ; J. R. Lake and R. A. J. Priston, unpublished observations), six other ts mutants (ts 10, 18, 50, 57, 104 and 117) were shown to be as avirulent as ts 49. If, like ts 49, their avirulence is due to their ts mutation, then it is interesting that they are all adjacent to ts 49 in the genetic map (McCahon et al., 1977) . The recombination data are inadequate to determine whether they represent one or several loci but they are all within the structural protein-coding region of the genome . The possible occurrence of avirulence loci in the non-structural coding regions of the genome requires the examination of more mutations in that region than were available in this study.
